Summit Wealth Group’s Zimmer Biomet ZBH Stock Holding History

Summit Wealth Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-15	Closed	-$2K	–	226
2021 Q2	$2K	Buy	+15	New	+$2.43K	﹤0.01%	172

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Summit Wealth Group's ZBH Position: Q3 2021 in Review

Summit Wealth Group sold out of Zimmer Biomet (ZBH) in Q3 2021, closing a stake of 15 shares — an estimated $2K sold.

Summit Wealth Group first reported a position in ZBH in Q2 2021 and held it in 1 quarter. The position peaked at $2K in Q2 2021. 982 funds tracked by Wall St. Rank hold ZBH as of Q3 2021.

Summit Wealth Group reported no remaining Zimmer Biomet position as of Q3 2021 after selling out during the quarter.
Summit Wealth Group sold 15 Zimmer Biomet shares in Q3 2021, an estimated $2K.
Summit Wealth Group first reported a position in Zimmer Biomet in Q2 2021 and held it in 1 quarter.
Summit Wealth Group's Zimmer Biomet position peaked at $2K in Q2 2021.
982 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2021.

Based on Summit Wealth Group's 13F filing for Q3 2021, filed 12 Nov 2021.